Клеточная терапия в кардиологии и сердечно-сосудистой хирургии: обзор рандомизированных исследований. Реалии и перспективы
Download
2. Assmus B., Honold J., Schachinger V. et al. Transcoronary transplantation of progenitor cells after myocardial infarction // N. Engl. J. Med. - 2006. - Vol. 355. - P. 1222-1232.
3. Baumgartner I., Piczek A. Constitutive expression of phVEGF165 after intramuscular Gene Transfer promotes collateral vessel development in patients with critical limb ischemia // Circulation. - 1995. - Vol. 91. - P. 2687-2692.
4. Brenner W., Aicher A., Eckey T. et al. 111In-labeled CD34+ hematopoetic progenitor cells in a rat myocardial infarction model // J. Nucl. Med. - 2004. - Vol. 45, № 3. - P. 512-518.
5. Etzion S., Battler A., Barbash I. M. et al. Influence of embryonic cardiomyocyte transplantation on the progression of heart failure in a rat model of extensive myocardial infarction // J. Mol. Cell. Cardiol. - 2001. - Vol. 33. - P. 1321-1330.
6. Fazel Sh., Liwen Chen, Weisel R. D. et al. Cell transplantation preserves cardiac function after infarction by infarct stabilization: Augmentation by stem cell factor // J. Thorac. Cardiovasc. Surg. - 2005. - Vol. 130, № 5. - P. 1310-1318.
7. Forrester J. S., Price M. J., Makkar R. R. Review: Current perspective. Stem cell repair of infarcted myocardium an overview for clinicians // Circulation. - 2003. - Vol. 108. - P. 1139-1145.
8. Fraidenraich D., Stillwell E., Romero E. et al. Rescue of cardiac defects in id knockout embryos by injection of embryonic stem cells // Science. - 2004. - Vol. 306, № 5694. - P. 239-240.
9. Frangoni J. V., Hajjar R. J. In vivo tracking of stem cells for clinical trials in cardiovascular disease // Circulation. - 2004. - Vol. 110, № 21. - P. 3378-3384.
10. Hofmann M., Wollert K. C., Meyer G. P. et al. Monitoring of bone marrow cell homing into the infarcted human myocardium // Ibid. - 2005. - Vol. 111. - P. 2198-2202.
11. Huang P. P., Zhu Sh. et al. Autologous transplantation of peripheral blood stem cells as an effective therapeutic approach for severe arteriosclerosis obliterations of lower extremities // Thromb. Heamost. - 2004. - Vol. 91. - P. 606-609.
12. Isner J., Baumgartner I. et al. Treatment of thromboangitis obliterans by intramuscular gene transfer of vascular endothelial growth factor; preliminary clinical results // J. Vasc. Surg. - 1998. - Vol. 28. - P. 964-975.
13. Isner J., Pieczek A. et al. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischemic limb // Lancet. - 1996. - Vol. 348. - P. 370-440.
14. Ittrich H., Lange C., Dahnke H. et al. Labeling of mesenchymal stem cells with different superparamagnetic particles of iron oxide and detectability with MRI at 3T // Rofo. - 2005. - Vol. 177, № 8. - P. 1151-1163.
15. Iwaguro H., Yamaguchi J., Kalka C. et al. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration // Circulation. - 2002. - Vol. 105. - P. 732-738.
16. Jain M., DerSimonian H., Brenner D. A. et al. Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction // Ibid. - 2001. - Vol. 103, № 14. - P. 1920-1927.
17. Janssens S., Dubois C., Bogaert J. et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomized controlled trial // Lancet. - 2006. - Vol. 367. - P. 113-121.
18. Kang H. J., Kim H. S., Zhang S. Y. et al. Effects of intracoronary infusion of peripheral blood stem cells mobilized with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomized clinical trial // Ibid. - 2004. - Vol. 363. - P. 751-756.
19. Kipshidze N., Kipiani K., Beridze N. et al. Therapeutic angiogenesis with modified fibrin meshwork for patients with critical limb ischemia // Angiogenesis Bench to Bedside / Eds J. Vossoughi, N. Kipshidze, J. Moses, J. Karanian. - Printed in Korea: Medical and Engineering Publishers, Inc., 2003. - Ch. 5. - P. 101-119.
20. Kocher A. A., Schuster M. D., Szaboles M. J. et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function // Nat. Med. - 2001. - Vol. 7. - P. 430-436.
21. Lederman R. F., Mendelson R. et al. Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC STUDY): a randomized trial // Lancet. - 2002. - Vol. 359. - P. 2053-2058.
22. Li R. K., Welsel R. D., Mickle D. A. et al. Autologous porcine heart cell transplantation improved heart function after a myocardial infarction // J. Thorac. Cardiovasc. Surg. - 2000. - Vol. 119. - P. 62-68.
23. Lunde K., Solheim S., Aakhus S. et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction // N. Engl. J. Med. - 2006. - Vol. 355. - P. 1199-1209.
24. Menasche Ph., Hagege A. A., Scorsin M. et al. Myoblast transplantation for heart failure // Lancet. - 2001. - Vol. 357, № 9252. - P. 279-280.
25. Meyer G. P., Wollert K. C., Lotz J. et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen moths follow-up data from the randomized, controlled BOOST (Bone Marrow Transfer to Enhance St-elevation infract regeneration) trial // Circulation. - 2006. - Vol. 113. - P. 1287-1294.
26. Perin E. C. Stem cell therapy for cardiovascular disease // Texas Heart Inst. J. - 2006. - Vol. 33, № 2. - P. 204-208.
27. Perin E. C., Dohmann H. F. R., Borojevic R. et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure // Circulation. - 2003. - Vol. 107. - P. 2294-2302.
28. Rosenzweig A. Cardiac cell therapy-mixed results from mixed cells // N. Engl. J. Med. - 2006. - Vol. 355, № 12. - P. 1274-1277.
29. Schachinger V., Assmus B., Britten M. B. et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial // J. Amer. Coll. Cardiol. - 2004. - Vol. 44. - P. 1690-1699.
30. Schachinger V., Erbs S., Elsasser A. et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction // N. Engl. J. Med. - 2006. - Vol. 355. - P. 1210-1221.
31. Shintani S., Murohara T., Ikeda H. et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction // Circulation. - 2001. - Vol. 103. - P. 2776-2779.
32. Tateishi-Yukama E., Matsubara H. et al. Therapeutic angiogenesis for patients with limb ischemia by autologous transplantation of bone- marrow cells: a pilot study and a randomized controlled trial // Lancet. - 2002. - Vol. 360. - P. 427-435.
33. Taylor D. A. Cellular cardiomyoplasty with autologous skeletal myoblasts for ischemic heart disease and heart failure (Commentary) // Curr. Control. Trials Cardiovasc. Med. - 2001. - Vol. 2, № 5. - P. 1468-1472.
34. Taylor D. A., Atkins B. Z. et al. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation // Nat. Med. - 1998. - Vol. 4. - P. 929-933.
35. Terada N., Hamazaki T., Oka M. et al. Bone marrow cells adopt phenotype of other cells by spontaneous cell fusion // Nature. - 2002. - Vol. 416. - P. 542-545.
36. Thompson R. B., Parsa C. J., Van den Bos Ej. et al. Video-assisted thoracoscopic transplantation of myoblasts into the heart // Ann. Thorac. Surg. - 2004. - Vol. 78. - P. 303-307.
37. Wollert K. C., Meyer G. P., Lotz J. et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomized controlled clinical trial // Lancet. - 2004. - Vol. 364. - P. 141-148.
References
1. Бокерия Л. А., Махалдиани З. Б., Сергеев А. В. и др. Современное состояние проблемы клеточной терапии сердечно-сосудистых заболеваний. Часть III. Торакоскопический способ доставки клеточных материалов в левый желудочек (экспериментальное исследование) // Бюллетень НЦССХ им. А. Н. Бакулева РАМН «Сердечно- сосудистые заболевания». - 2006. - Т. 7, № 5. - С. 24-30.2. Assmus B., Honold J., Schachinger V. et al. Transcoronary transplantation of progenitor cells after myocardial infarction // N. Engl. J. Med. - 2006. - Vol. 355. - P. 1222-1232.
3. Baumgartner I., Piczek A. Constitutive expression of phVEGF165 after intramuscular Gene Transfer promotes collateral vessel development in patients with critical limb ischemia // Circulation. - 1995. - Vol. 91. - P. 2687-2692.
4. Brenner W., Aicher A., Eckey T. et al. 111In-labeled CD34+ hematopoetic progenitor cells in a rat myocardial infarction model // J. Nucl. Med. - 2004. - Vol. 45, № 3. - P. 512-518.
5. Etzion S., Battler A., Barbash I. M. et al. Influence of embryonic cardiomyocyte transplantation on the progression of heart failure in a rat model of extensive myocardial infarction // J. Mol. Cell. Cardiol. - 2001. - Vol. 33. - P. 1321-1330.
6. Fazel Sh., Liwen Chen, Weisel R. D. et al. Cell transplantation preserves cardiac function after infarction by infarct stabilization: Augmentation by stem cell factor // J. Thorac. Cardiovasc. Surg. - 2005. - Vol. 130, № 5. - P. 1310-1318.
7. Forrester J. S., Price M. J., Makkar R. R. Review: Current perspective. Stem cell repair of infarcted myocardium an overview for clinicians // Circulation. - 2003. - Vol. 108. - P. 1139-1145.
8. Fraidenraich D., Stillwell E., Romero E. et al. Rescue of cardiac defects in id knockout embryos by injection of embryonic stem cells // Science. - 2004. - Vol. 306, № 5694. - P. 239-240.
9. Frangoni J. V., Hajjar R. J. In vivo tracking of stem cells for clinical trials in cardiovascular disease // Circulation. - 2004. - Vol. 110, № 21. - P. 3378-3384.
10. Hofmann M., Wollert K. C., Meyer G. P. et al. Monitoring of bone marrow cell homing into the infarcted human myocardium // Ibid. - 2005. - Vol. 111. - P. 2198-2202.
11. Huang P. P., Zhu Sh. et al. Autologous transplantation of peripheral blood stem cells as an effective therapeutic approach for severe arteriosclerosis obliterations of lower extremities // Thromb. Heamost. - 2004. - Vol. 91. - P. 606-609.
12. Isner J., Baumgartner I. et al. Treatment of thromboangitis obliterans by intramuscular gene transfer of vascular endothelial growth factor; preliminary clinical results // J. Vasc. Surg. - 1998. - Vol. 28. - P. 964-975.
13. Isner J., Pieczek A. et al. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischemic limb // Lancet. - 1996. - Vol. 348. - P. 370-440.
14. Ittrich H., Lange C., Dahnke H. et al. Labeling of mesenchymal stem cells with different superparamagnetic particles of iron oxide and detectability with MRI at 3T // Rofo. - 2005. - Vol. 177, № 8. - P. 1151-1163.
15. Iwaguro H., Yamaguchi J., Kalka C. et al. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration // Circulation. - 2002. - Vol. 105. - P. 732-738.
16. Jain M., DerSimonian H., Brenner D. A. et al. Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction // Ibid. - 2001. - Vol. 103, № 14. - P. 1920-1927.
17. Janssens S., Dubois C., Bogaert J. et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomized controlled trial // Lancet. - 2006. - Vol. 367. - P. 113-121.
18. Kang H. J., Kim H. S., Zhang S. Y. et al. Effects of intracoronary infusion of peripheral blood stem cells mobilized with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomized clinical trial // Ibid. - 2004. - Vol. 363. - P. 751-756.
19. Kipshidze N., Kipiani K., Beridze N. et al. Therapeutic angiogenesis with modified fibrin meshwork for patients with critical limb ischemia // Angiogenesis Bench to Bedside / Eds J. Vossoughi, N. Kipshidze, J. Moses, J. Karanian. - Printed in Korea: Medical and Engineering Publishers, Inc., 2003. - Ch. 5. - P. 101-119.
20. Kocher A. A., Schuster M. D., Szaboles M. J. et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function // Nat. Med. - 2001. - Vol. 7. - P. 430-436.
21. Lederman R. F., Mendelson R. et al. Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC STUDY): a randomized trial // Lancet. - 2002. - Vol. 359. - P. 2053-2058.
22. Li R. K., Welsel R. D., Mickle D. A. et al. Autologous porcine heart cell transplantation improved heart function after a myocardial infarction // J. Thorac. Cardiovasc. Surg. - 2000. - Vol. 119. - P. 62-68.
23. Lunde K., Solheim S., Aakhus S. et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction // N. Engl. J. Med. - 2006. - Vol. 355. - P. 1199-1209.
24. Menasche Ph., Hagege A. A., Scorsin M. et al. Myoblast transplantation for heart failure // Lancet. - 2001. - Vol. 357, № 9252. - P. 279-280.
25. Meyer G. P., Wollert K. C., Lotz J. et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen moths follow-up data from the randomized, controlled BOOST (Bone Marrow Transfer to Enhance St-elevation infract regeneration) trial // Circulation. - 2006. - Vol. 113. - P. 1287-1294.
26. Perin E. C. Stem cell therapy for cardiovascular disease // Texas Heart Inst. J. - 2006. - Vol. 33, № 2. - P. 204-208.
27. Perin E. C., Dohmann H. F. R., Borojevic R. et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure // Circulation. - 2003. - Vol. 107. - P. 2294-2302.
28. Rosenzweig A. Cardiac cell therapy-mixed results from mixed cells // N. Engl. J. Med. - 2006. - Vol. 355, № 12. - P. 1274-1277.
29. Schachinger V., Assmus B., Britten M. B. et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial // J. Amer. Coll. Cardiol. - 2004. - Vol. 44. - P. 1690-1699.
30. Schachinger V., Erbs S., Elsasser A. et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction // N. Engl. J. Med. - 2006. - Vol. 355. - P. 1210-1221.
31. Shintani S., Murohara T., Ikeda H. et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction // Circulation. - 2001. - Vol. 103. - P. 2776-2779.
32. Tateishi-Yukama E., Matsubara H. et al. Therapeutic angiogenesis for patients with limb ischemia by autologous transplantation of bone- marrow cells: a pilot study and a randomized controlled trial // Lancet. - 2002. - Vol. 360. - P. 427-435.
33. Taylor D. A. Cellular cardiomyoplasty with autologous skeletal myoblasts for ischemic heart disease and heart failure (Commentary) // Curr. Control. Trials Cardiovasc. Med. - 2001. - Vol. 2, № 5. - P. 1468-1472.
34. Taylor D. A., Atkins B. Z. et al. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation // Nat. Med. - 1998. - Vol. 4. - P. 929-933.
35. Terada N., Hamazaki T., Oka M. et al. Bone marrow cells adopt phenotype of other cells by spontaneous cell fusion // Nature. - 2002. - Vol. 416. - P. 542-545.
36. Thompson R. B., Parsa C. J., Van den Bos Ej. et al. Video-assisted thoracoscopic transplantation of myoblasts into the heart // Ann. Thorac. Surg. - 2004. - Vol. 78. - P. 303-307.
37. Wollert K. C., Meyer G. P., Lotz J. et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomized controlled clinical trial // Lancet. - 2004. - Vol. 364. - P. 141-148.
